Skip to Content
MDPIMDPI

Advanced

Findings, Insights and Perspectives on Central Nervous System Tumors

Propose a Topic

Topic Information

Dear Colleagues,

Central nervous system (CNS) cancers are neoplastic diseases stemming from the brain and its surrounding structures, with increasing incidence, and high mortality and morbidity rates worldwide. They are characterized by their aggressive nature, marked heterogeneity and adaptation to chemoresistance, leading to a poor prognosis and clinical outcome. With the ongoing advances in research, the medical field is trying to abandon the “one size fits all” philosophy and adopt a personalized medicine approach, developing novel drug and formulation strategies that can target specific disease biomarkers. The aim of this Topic is to provide a forum for researchers and clinicians to share their latest findings, insights, and perspectives on CNS tumors. We welcome original research and review articles on a range of topics related to CNS neoplasms, including, but not limited to, the following: (1) the molecular and cellular mechanisms of cancer initiation, progression, and resistance; (2) advances in diagnosis and treatment; (3) novel drug delivery strategies for cancer therapy; (4) new diagnostic and prognostic biomarkers; (5) innovative 3D microphysiological models for cancer and tumor microenvironment research; and (6) the synergy of machine learning in designing more efficient therapies.

Dr. João Basso
Dr. Carla Vitorino
Dr. Rui Vitorino
Dr. Ana Fortuna
Topic Editors

Keywords

  • artificial intelligence
  • biomarkers
  • brain cancer
  • drug delivery
  • drug repurposing
  • glioblastoma
  • molecular signatures
  • nanomaterials
  • organoids
  • targeted therapy

Participating Journals

Cancers
Open Access
37,953 Articles
Launched in 2009
4.8Impact Factor
9.0CiteScore
18 DaysSubmission to First Decision
3 DaysAcceptance to Publication
Q2Highest JCR Category Ranking
Cells
Open Access
21,759 Articles
Launched in 2012
6.0Impact Factor
11.4CiteScore
15 DaysSubmission to First Decision
3 DaysAcceptance to Publication
Q2Highest JCR Category Ranking
Diseases
Open Access
1,901 Articles
Launched in 2013
3.7Impact Factor
4.2CiteScore
22 DaysSubmission to First Decision
3 DaysAcceptance to Publication
Q2Highest JCR Category Ranking
Nanomaterials
Open Access
22,943 Articles
Launched in 2010
4.8Impact Factor
10.3CiteScore
13 DaysSubmission to First Decision
3 DaysAcceptance to Publication
Q2Highest JCR Category Ranking
Pharmaceutics
Open Access
15,093 Articles
Launched in 2009
6.9Impact Factor
12.5CiteScore
16 DaysSubmission to First Decision
3 DaysAcceptance to Publication
Q1Highest JCR Category Ranking
Preprints

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

i. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.

ii. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.

iii. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.

iv. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.

v. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers